MultNAT® HPV16/18 Assay
The kit is an automated, in vitro nucleic acid amplification test used to qualitatively detect DNA of human Papillimavirus (HPV) Type 16 and Type 18 from cervical specimens. The kit is designed for professional laboratory use.
- Fast: Get result from sample in about 77 minutes
- Simple: Fully automated workflow. Sample-in, result-out
- Safe: All-in-one cartridge with integrated UDG anti-contamination system
- Accuracy: high sensitivity, high specificity ensures precise pathogen identification
Clinical Value
Long-term and pesistant infection of HPV type 16 and type 18 can cause 70% cervical cancer.
Precise HPV Detection: Enables rapid and accurate diagnosis of HPV infections, supporting timely clinical decisions and appropriate patient management
Ongoing Challenges
Cervical cancer, caused almost exclusively by oncogenic types of HPV, is an important public health problem globally. In 2020, an estimated 604,000 women were diagnosed with cervical cancer worldwide. By 2022, this data has increased to 662,000 and approximately 34,000 women died from the disease.
- Asymptomatic carrier: posing great difficulties for clinical management-without regular screening, asymptomatic carriers may become silent sources of transmission
- Complex Testing Workflow: Multiple limitations of traditional methods
